Fujisawa

Still, Mebiopharm CEO Tadashi Fujisawa said the company will aim to enhance market confidence by following through on its promise to turn its operations profitable this fiscal year.

First Listing on Alternative Tokyo Market Falls Flat Kana Inagaki 2011

"We selected Tokyo Aim because we found the market attractive due to its flexibility and speediness in various procedures," Chief Executive Officer Tadashi Fujisawa said at a news conference.

Mebiopharm Applies to Be First on Tokyo Aim Market Kana Inagaki 2011

Career: Joined in 1980 Fujisawa Pharmaceutical Co., which merged with Yamanouchi Pharmaceutical Co. in 2005.

Astellas Pharma Eyes Unmet Medical Needs Kana Inagaki 2011

"We take seriously the share assessment, but we believe we can win investor support through steady progress in our business plan and in the development of drugs," Fujisawa said at a news conference.

First Listing on Alternative Tokyo Market Falls Flat Kana Inagaki 2011

"We selected Tokyo Aim because we found the market attractive due to its flexibility and speediness in various procedures," Chief Executive Officer Tadashi Fujisawa said at a news conference.

Mebiopharm Applies to Be First on Tokyo Aim Market Kana Inagaki 2011

As we were talking and viewing on Skype, Kevin was experiencing aftershocks, and we could see him tuned into what was happening to his bedroom in a high-rise apartment in Fujisawa, Japan.

Japan earthquake and tsunami: Your stories 2011

The deal represents the first major acquisition by Astellas after the company was created from a merger of Yamanouchi and Fujisawa in 200

Astellas to Buy OSI Pharmaceuticals for $4 Billion 2010

Japanese scholars also note the export of copper and tin from Yunnan; see Yoshimi Fujisawa, "Biruma Unnan ruto to tozai bunka no koryu" (the Burma-Yunnan transportation route and the East-West cultural contact: The cultural origins of Nanzhao), Iwate Shigaku Kenkyu 25 (1953): 10-21. back

Between Winds and Clouds: The Making of Yunnan (Second Century BCE to Twentieth Century CE) 2008

Note 18: Japanese scholars have noticed the close relationship between China's Central Asian policy and its advance into the Southwest; see Yoshimi Fujisawa, "Biruma Unnan ruto to tozai bunka no koryu" (The Burma-Yunnan transportation route and East-West cultural contacts: the cultural origins of Nanzhao), Iwate Shigaku Kenkyu 25 (1953): 10-21.

Between Winds and Clouds: The Making of Yunnan (Second Century BCE to Twentieth Century CE) 2008

Ltd. and Fujisawa Pharmaceutical Co.Ltd. It began exploring expansion options in 2007 and acquired the site from GlenStar in the fall of 2009.

Japanese Firm Makes a Mark in Chicago 2010